Castlight Health, inc. (NYSE:CSLT) President Robert Derek Newell acquired 30,000 shares of the firm’s stock in a transaction dated Friday, October 27th. The shares were purchased at an average cost of $3.95 per share, for a total transaction of $118,500.00. Following the completion of the acquisition, the president now directly owns 128,671 shares in the company, valued at $508,250.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Robert Derek Newell also recently made the following trade(s):

  • On Wednesday, November 1st, Robert Derek Newell acquired 30,468 shares of Castlight Health, inc. stock. The shares were purchased at an average cost of $3.95 per share, for a total transaction of $120,348.60.

Castlight Health, inc. (NYSE:CSLT) last announced its quarterly earnings data on Wednesday, October 25th. The software maker reported ($0.05) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.07) by $0.02. Castlight Health, inc. had a negative return on equity of 32.57% and a negative net margin of 45.14%. The firm had revenue of $34.60 million for the quarter, compared to the consensus estimate of $34.61 million. During the same quarter last year, the business posted ($0.05) earnings per share. The firm’s revenue was up 35.7% compared to the same quarter last year.

ILLEGAL ACTIVITY NOTICE: “Castlight Health, inc. (CSLT) President Robert Derek Newell Buys 30,000 Shares” was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/11/02/castlight-health-inc-cslt-president-robert-derek-newell-buys-30000-shares.html.

A number of institutional investors have recently made changes to their positions in CSLT. Stifel Financial Corp lifted its position in Castlight Health, inc. by 4.3% during the first quarter. Stifel Financial Corp now owns 36,500 shares of the software maker’s stock worth $133,000 after buying an additional 1,500 shares in the last quarter. FMR LLC raised its position in Castlight Health, inc. by 3.4% in the first quarter. FMR LLC now owns 7,665,919 shares of the software maker’s stock valued at $27,980,000 after purchasing an additional 254,804 shares during the period. TIAA CREF Investment Management LLC raised its position in Castlight Health, inc. by 2.1% in the first quarter. TIAA CREF Investment Management LLC now owns 108,032 shares of the software maker’s stock valued at $394,000 after purchasing an additional 2,210 shares during the period. Vanguard Group Inc. raised its position in Castlight Health, inc. by 7.6% in the first quarter. Vanguard Group Inc. now owns 2,673,760 shares of the software maker’s stock valued at $9,760,000 after purchasing an additional 189,359 shares during the period. Finally, Geode Capital Management LLC raised its position in Castlight Health, inc. by 2.7% in the first quarter. Geode Capital Management LLC now owns 306,367 shares of the software maker’s stock valued at $1,118,000 after purchasing an additional 8,057 shares during the period. Hedge funds and other institutional investors own 41.29% of the company’s stock.

CSLT has been the topic of several recent research reports. Zacks Investment Research upgraded Castlight Health, inc. from a “hold” rating to a “buy” rating and set a $4.50 price target on the stock in a report on Monday. Canaccord Genuity restated a “buy” rating and set a $7.00 price target on shares of Castlight Health, inc. in a report on Thursday, October 26th. Chardan Capital decreased their price target on Castlight Health, inc. from $6.50 to $6.30 and set a “buy” rating on the stock in a report on Thursday, October 26th. Cantor Fitzgerald restated a “hold” rating and set a $5.00 price target on shares of Castlight Health, inc. in a report on Wednesday, October 25th. Finally, BidaskClub lowered Castlight Health, inc. from a “hold” rating to a “sell” rating in a report on Wednesday, October 18th. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $5.22.

About Castlight Health, inc.

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Insider Buying and Selling by Quarter for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.